The MUC5B (rs35705950) promoter polymorphism is associated with IPF, interstitial lung abnormalities (ILA), and interstitial lung changes after COVID-19, and the T minor allele has been shown to slow the progression of disease [11-13]. This evidence concerns the gene MUC5B and idiopathic interstitial pneumonia.